These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25149424)

  • 21. The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.
    Piérard GE; Piérard-Franchimont C; Szepetiuk G; Paquet P; Quatresooz P
    Expert Opin Biol Ther; 2010 Aug; 10(8):1197-208. PubMed ID: 20560729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psoriasis: classical and emerging comorbidities.
    Oliveira Mde F; Rocha Bde O; Duarte GV
    An Bras Dermatol; 2015; 90(1):9-20. PubMed ID: 25672294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk.
    Kleyn CE; Talbot PS; Mehta NN; Sampogna F; Bundy C; Ashcroft DM; Kimball AB; van de Kerkhof PCM; Griffiths CEM; Valenzuela F; van der Walt JM; Aberra T; Puig L
    Acta Derm Venereol; 2020 Jan; 100(1):adv00020. PubMed ID: 31742649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psoriasis and its comorbidities.
    Onumah N; Kircik LH
    J Drugs Dermatol; 2012 May; 11(5 Suppl):s5-10. PubMed ID: 22644770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for detection of individual risk for comorbidities in patients with psoriasis.
    Wohlrab J; Fiedler G; Gerdes S; Nast A; Philipp S; Radtke MA; Thaçi D; Koenig W; Pfeiffer AF; Härter M; Schön MP
    Arch Dermatol Res; 2013 Mar; 305(2):91-8. PubMed ID: 23377136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanistic basis for psoriasis immunopathogenesis: translating genotype to phenotype. Report of a workshop, Venice, 2012.
    Bachelez H; Viguier M; Tebbey PW; Lowes M; Suárez-Fariñas M; Costanzo A; Nestle FO
    Br J Dermatol; 2013 Aug; 169(2):283-6. PubMed ID: 23941252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation, atherosclerosis, and psoriasis.
    Siegel D; Devaraj S; Mitra A; Raychaudhuri SP; Raychaudhuri SK; Jialal I
    Clin Rev Allergy Immunol; 2013 Apr; 44(2):194-204. PubMed ID: 22359071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease.
    Bonanad C; González-Parra E; Rivera R; Carrascosa JM; Daudén E; Olveira A; Botella-Estrada R
    Actas Dermosifiliogr; 2017 Nov; 108(9):800-808. PubMed ID: 28610662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging Associations Between Neutrophils, Atherosclerosis, and Psoriasis.
    Sanda GE; Belur AD; Teague HL; Mehta NN
    Curr Atheroscler Rep; 2017 Oct; 19(12):53. PubMed ID: 29086088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoriasis and metabolic syndrome.
    Takahashi H; Iizuka H
    J Dermatol; 2012 Mar; 39(3):212-8. PubMed ID: 22035413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis.
    Cai J; Cui L; Wang Y; Li Y; Zhang X; Shi Y
    Front Pharmacol; 2021; 12():774808. PubMed ID: 34803716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiometabolic Disorders in Psoriatic Disease.
    Sobchak C; Eder L
    Curr Rheumatol Rep; 2017 Aug; 19(10):63. PubMed ID: 28844116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms.
    Yim KM; Armstrong AW
    Rheumatol Int; 2017 Jan; 37(1):97-105. PubMed ID: 27221457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein Metabolism and Inflammation in Patients With Psoriasis.
    Armstrong EJ; Krueger JG
    Am J Cardiol; 2016 Aug; 118(4):603-9. PubMed ID: 27392508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can early treatment with biologicals modify the natural history of comorbidities?
    Vena GA; Vestita M; Cassano N
    Dermatol Ther; 2010; 23(2):181-93. PubMed ID: 20415826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A new view of psoriasis].
    Jullien D; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):3-7. PubMed ID: 20510168
    [No Abstract]   [Full Text] [Related]  

  • 37. Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences.
    Boehncke WH
    Front Immunol; 2018; 9():579. PubMed ID: 29675020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The concept of psoriasis as a systemic inflammation: implications for disease management.
    Reich K
    J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():3-11. PubMed ID: 22356630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
    Hu SC; Lan CE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis comorbidities: complications and benefits of immunobiological treatment.
    Carvalho AV; Romiti R; Souza CD; Paschoal RS; Milman LM; Meneghello LP
    An Bras Dermatol; 2016; 91(6):781-789. PubMed ID: 28099601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.